4dmedical Share Price and Company Fundamentals
Last traded: Today at 11:27 PM
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in medical research technology and development of a non invasive respiratory imaging solution. It offers CT:VQ, non-contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company has partnership with AstraZeneca to launch and expand a lung health screening program; and a contractual engagement with GlaxoSmithKline to provide its proprietary quantitative lung imaging analytics in support of pulmonary drug development and clinical research. 4DMedical Limited was incorporated in 2012 and is based in Carlton, Australia.
Key Metrics
PE ratio
-
PB ratio
8.28
Dividend yield
0.00%
Beta
1.94
Market cap
$1.42B
Enterprise value
$1.33B
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Full time employees | 181 |
| Website | https://4dmedical.com |
| Mailing address | Melbourne Connect Level 7 700 Swanston Street Carlton VIC 3053 Australia |
| Phone / Fax | 61 3 9545 5940 / |
Dividends
More: 4dmedical Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$-
Payout ratio
-
5Y Avg. yield
-%
4dmedical paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Nov 2026, following are the company executives and directors listed on 4dmedical.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Julian Sutton B.Sc., C.F.A. | Executive Chairman | ||
| Dr. Andreas Fouras B.E., M.A.I.C.D., Ph.D. | Founder, MD, CEO & Director | ||
| Mr. Matt Tucker | Chief Commercial Officer | ||
| Mr. Chris Cox | Chief Financial Officer | ||
| Ms. Beth Plunkett J.D. | General Counsel | ||
| Dr. Aidan Jamison B.E., Ph.D. | Senior Vice President of Engineering | ||
| Ms. Rachael Tenkaten | Senior Vice President of Product | ||
| Dr. Greg T. Mogel M.D. | Chief Medical Officer | ||
| Mr. David Hannes B.S., M.B.A. | Senior Vice President of Global Business Development | ||
| Mr. Hamish George B.Com., C.A. | Company Secretary |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-813.68%
Return on assets
-15.61%
Return on equity
-174.43%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of 4dmedical is 1.42B and its enterprise value is 1.33B. The enterprise value to revenue ratio of 4DX is 188.06. The enterprise value to EBITDA ratio of 4DX is -23.71.
The 4DX's stocks Beta value is 1.94 making it 94% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to 4dmedical (4DX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
4dmedical (ASX:4DX) Frequently Asked Questions
1. What is 4dmedical's Stock Symbol?
4dmedical trades on ASX under the ticker symbol "4DX".
2. What is 4dmedical's stock price today?
One share of 4DX stock can currently be purchased for approximately $2.36.
3. How can I contact 4dmedical?
4dmedical's mailing address is Melbourne Connect Level 7 700 Swanston Street Carlton VIC 3053 Australia. The company can be reached via phone at 61 3 9545 5940.
4. What is 4dmedical's official website?
The official website of 4dmedical is https://4dmedical.com.